131 related articles for article (PubMed ID: 33785723)
21. Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats.
Fearon KC; Tisdale MJ; Preston T; Plumb JA; Calman KC
Br J Cancer; 1985 Jul; 52(1):87-92. PubMed ID: 2861842
[TBL] [Abstract][Full Text] [Related]
22. [Ultrastructural changes in endothelial cells of blood capillaries of the Walker 256 carcinosarcoma while treated with melatonin].
Ovsianko EV; Pustovetova MG; Samsonova EN; Ovsianko IaU; Fedina RG; Kulishenko AO; Vinogradov AS
Vopr Onkol; 2014; 60(2):80-3. PubMed ID: 24919267
[TBL] [Abstract][Full Text] [Related]
23. Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin.
Todor IN; Lukyanova NY; Shvets YV; Lozovska YV; Chekhun VF
Exp Oncol; 2015 Mar; 37(1):19-22. PubMed ID: 25804226
[TBL] [Abstract][Full Text] [Related]
24. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
25. [Kinetic study of the reaction of regional lymph nodes and the spleen to the growth of Walker carcinosarcoma].
Volodarskaia TA; Erokhin VN
Izv Akad Nauk SSSR Biol; 1974; (2):289-94. PubMed ID: 4461751
[No Abstract] [Full Text] [Related]
26. [Effect of vasopressin gene expression on the growth of Walker 256 carcinosarcoma in rats].
Khegaĭ II; Popova NA; Ivanova LN
Genetika; 2006 Jul; 42(7):993-5. PubMed ID: 16915932
[TBL] [Abstract][Full Text] [Related]
27. Effects of sera and spleen cells isolated from partially hepatectomized rats on the growth of Walker-256 tumour.
Ramantanis G; Deliconstantinos G
Biomed Pharmacother; 1985; 39(9-10):482-6. PubMed ID: 3833307
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study for the expression of Bcl-2 family proteins in Walker 256 carcinosarcoma cells under the influence of cytostatic drugs.
Ovsjanko EV; Lushnikova EL; Larionov PM; Arkhipov SA; Nepomnyashchikh LM; Efremov AV; Ovsjanko YU
Bull Exp Biol Med; 2009 Oct; 148(4):650-5. PubMed ID: 20396763
[TBL] [Abstract][Full Text] [Related]
29. Antitumoral and antioxidant effects of a hydroalcoholic extract of cat's claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model.
Dreifuss AA; Bastos-Pereira AL; Avila TV; Soley Bda S; Rivero AJ; Aguilar JL; Acco A
J Ethnopharmacol; 2010 Jul; 130(1):127-33. PubMed ID: 20435132
[TBL] [Abstract][Full Text] [Related]
30. Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs.
Yalovenko TM; Todor IM; Lukianova NY; Chekhun VF
Exp Oncol; 2016 Jun; 38(2):84-8. PubMed ID: 27356575
[TBL] [Abstract][Full Text] [Related]
31. Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
Juraschek M; Seibel MJ; Woitge HW; Krempien B; Bauss F
Bone; 2000 May; 26(5):475-83. PubMed ID: 10773587
[TBL] [Abstract][Full Text] [Related]
32. Effect of diets with different protein levels on the growth of Walker 256 carcinosarcoma in rats.
Waitzberg DL; Gonçalves EL; Faintuch J; Bevilacqua LR; Rocha CL; Cologni AM
Braz J Med Biol Res; 1989; 22(4):447-55. PubMed ID: 2511986
[TBL] [Abstract][Full Text] [Related]
33. METALLOPROTEINS DURING DEVELOPMENT OF WALKER-256 CARCINOSARCOMA RESISTANT PHENOTYPE.
Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich II; Shvets YV; Lukianova NY; Todor IM; Demash DV; Pavlova AA; Naleskina LA
Ukr Biochem J; 2015; 87(2):103-12. PubMed ID: 26255344
[TBL] [Abstract][Full Text] [Related]
34. BIOMAGNETISM OF DRUG-SENSITIVE AND DRUG-RESISTANT MALIGNANT TUMORS AFTER INJECTION OF FERROMAGNETIC NANOCOMPOSITE.
Todor IN; Lukianova NY; Primin MA; Nedayvoda IV; Chekhun VF
Exp Oncol; 2022 Dec; 44(4):320-323. PubMed ID: 36811536
[TBL] [Abstract][Full Text] [Related]
35. Glucagon and epinephrine effect on blood glucose levels in rats carrying Yoshida solid sarcoma and Walker-256 carcinosarcoma.
de la Piedra C; Rubert LD; Jerez E; Castro Mendoza HJ
Biomedicine; 1979 Sep; 31(5):139-41. PubMed ID: 508897
[TBL] [Abstract][Full Text] [Related]
36. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
Kamocka M; Kaplinska K; Mielicki WP
Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
[TBL] [Abstract][Full Text] [Related]
37. Proliferation of Walker 256 carcinosarcoma cells: effect of whole-body hyperthermia and antitumor agents.
Lushnikova EL; Ovsyanko EV; Nepomnyashchikh LM; Efremov AV; Morozov DV
Bull Exp Biol Med; 2011 Nov; 152(1):146-52. PubMed ID: 22803062
[TBL] [Abstract][Full Text] [Related]
38. [Experimental model of Walker 256 carcinosarcoma in rats bladder].
Dornelas CA; Almeida PR; Nascimento GL; Lima EB; Moraes MO
Acta Cir Bras; 2006; 21(1):38-42. PubMed ID: 16491221
[TBL] [Abstract][Full Text] [Related]
39. Urinary cyclic AMP and bone histology in Walker carcinosarcoma: evidence of parathyroid hormone-like activity.
Schmidt-Gayk H; Löhrke H; Fischkal A; Goerttler K; Hofmann F
Eur J Cancer (1965); 1979 Oct; 15(10):1211-8. PubMed ID: 230054
[No Abstract] [Full Text] [Related]
40. [The effect of ferromagnet particles on the growth of Walker carcinosarcoma 256 in Wistar rats].
Volkonskiĭ VA
Eksp Onkol; 1990; 12(2):74-6. PubMed ID: 2318139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
